Rush University Medical Center is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Rush University Medical Center has participated in 1474 clinical trials with 316 currently active.
Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, NSABP Foundation Inc, Vericel Corporation.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Chicago
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush University Medical Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush University Medical Center has 1474 clinical trials on record, with 316 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Rush University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.